Davey S. Scoon

Chair of the Board of Trustees, Allianz Global Investors

Davey Scoon’s business career has included senior executive positions in finance and administration at Tom’s of Maine, Inc., Sunlife Financial U.S. and Liberty Funds Group of Boston (formerly Colonial Management), as well as serving as a CPA with Price Waterhouse & Company. He is currently chairman of the Board of Trustees for Allianz Global Investors and a director and chairman of the Audit Committee of AMAG Pharmaceuticals, Inc. Among other roles, he previously served as non-executive chairman of Tufts Health Plan. Davey is also an adjunct professor teaching accounting at the University of Wisconsin-Madison. He earned an MBA from Harvard Business School and a BBA in Business Administration from the University of Wisconsin.

Team members

David Chiswell, Ph.D.

Chairman of the Board, Albireo; Chief Executive Officer, Kymab

Julia R. Brown

Former Executive Vice President and Advisor to the CEO, Amylin Pharmaceuticals (retired)

Michael Gutch, Ph.D.

Chief Business Officer and Chief Financial Officer, Entasis Therapeutics

Roger A. Jeffs, Ph.D.

Former President and co-CEO, United Therapeutics (retired)

Heather Preston, M.D.

Partner & Managing Director, TPG Biotech

Davey S. Scoon

Chair of the Board of Trustees, Allianz Global Investors

Ron Cooper

President and Chief Executive Officer